488 related articles for article (PubMed ID: 20685603)
21. PKC Delta (PKCdelta) promotes tumoral progression of human ductal pancreatic cancer.
Mauro LV; Grossoni VC; Urtreger AJ; Yang C; Colombo LL; Morandi A; Pallotta MG; Kazanietz MG; Bal de Kier Joffé ED; Puricelli LL
Pancreas; 2010 Jan; 39(1):e31-41. PubMed ID: 19924022
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma.
Linder S; Castaños-Velez E; von Rosen A; Biberfeld P
Hepatogastroenterology; 2001; 48(41):1321-7. PubMed ID: 11677955
[TBL] [Abstract][Full Text] [Related]
23. The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma.
Deng X; Ewton DZ; Li S; Naqvi A; Mercer SE; Landas S; Friedman E
Cancer Res; 2006 Apr; 66(8):4149-58. PubMed ID: 16618736
[TBL] [Abstract][Full Text] [Related]
24. The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma.
Erkan M; Michalski CW; Rieder S; Reiser-Erkan C; Abiatari I; Kolb A; Giese NA; Esposito I; Friess H; Kleeff J
Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1155-61. PubMed ID: 18639493
[TBL] [Abstract][Full Text] [Related]
25. Thrombospondin-1 expression as a prognostic predictor of pancreatic ductal carcinoma.
Tobita K; Kijima H; Dowaki S; Oida Y; Kashiwagi H; Ishii M; Sugio Y; Sekka T; Ohtani Y; Tanaka M; Inokuchi S; Makuuchi H
Int J Oncol; 2002 Dec; 21(6):1189-95. PubMed ID: 12429967
[TBL] [Abstract][Full Text] [Related]
26. Actinin-4 expression in primary and metastasized pancreatic ductal adenocarcinoma.
Welsch T; Keleg S; Bergmann F; Bauer S; Hinz U; Schmidt J
Pancreas; 2009 Nov; 38(8):968-76. PubMed ID: 19672209
[TBL] [Abstract][Full Text] [Related]
27. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis.
Maruyama Y; Ono M; Kawahara A; Yokoyama T; Basaki Y; Kage M; Aoyagi S; Kinoshita H; Kuwano M
Cancer Res; 2006 Jun; 66(12):6233-42. PubMed ID: 16778198
[TBL] [Abstract][Full Text] [Related]
28. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis.
Kayed H; Kleeff J; Keleg S; Felix K; Giese T; Berger MR; Büchler MW; Friess H
Cancer Lett; 2007 Jan; 245(1-2):171-83. PubMed ID: 16488077
[TBL] [Abstract][Full Text] [Related]
29. Wnt2 protein plays a role in the progression of pancreatic cancer promoted by pancreatic stellate cells.
Xu Y; Li H; Huang C; Zhao T; Zhang H; Zheng C; Ren H; Hao J
Med Oncol; 2015 Apr; 32(4):97. PubMed ID: 25731618
[TBL] [Abstract][Full Text] [Related]
30. Periostin, a matrix specific protein, is associated with proliferation and invasion of pancreatic cancer.
Ben QW; Jin XL; Liu J; Cai X; Yuan F; Yuan YZ
Oncol Rep; 2011 Mar; 25(3):709-16. PubMed ID: 21225237
[TBL] [Abstract][Full Text] [Related]
31. CD271⁺ subpopulation of pancreatic stellate cells correlates with prognosis of pancreatic cancer and is regulated by interaction with cancer cells.
Fujiwara K; Ohuchida K; Mizumoto K; Shindo K; Eguchi D; Kozono S; Ikenaga N; Ohtsuka T; Takahata S; Aishima S; Tanaka M
PLoS One; 2012; 7(12):e52682. PubMed ID: 23300742
[TBL] [Abstract][Full Text] [Related]
32. Heparanase expression in primary and metastatic pancreatic cancer.
Koliopanos A; Friess H; Kleeff J; Shi X; Liao Q; Pecker I; Vlodavsky I; Zimmermann A; Büchler MW
Cancer Res; 2001 Jun; 61(12):4655-9. PubMed ID: 11406531
[TBL] [Abstract][Full Text] [Related]
33. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.
Ohuchida K; Mizumoto K; Miyasaka Y; Yu J; Cui L; Yamaguchi H; Toma H; Takahata S; Sato N; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
J Pathol; 2007 Nov; 213(3):275-82. PubMed ID: 17940995
[TBL] [Abstract][Full Text] [Related]
34. Galectin-1 secreted by activated stellate cells in pancreatic ductal adenocarcinoma stroma promotes proliferation and invasion of pancreatic cancer cells: an in vitro study on the microenvironment of pancreatic ductal adenocarcinoma.
Xue X; Lu Z; Tang D; Yao J; An Y; Wu J; Li Q; Gao W; Xu Z; Qian Z; Dai C; Wei J; Miao Y; Jiang K
Pancreas; 2011 Aug; 40(6):832-9. PubMed ID: 21747316
[TBL] [Abstract][Full Text] [Related]
35. Epithelial and stromal expression of syndecan-2 in pancreatic carcinoma.
Hrabar D; Aralica G; Gomercic M; Ljubicic N; Kruslin B; Tomas D
Anticancer Res; 2010 Jul; 30(7):2749-53. PubMed ID: 20683009
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.
Haqq J; Howells LM; Garcea G; Metcalfe MS; Steward WP; Dennison AR
Eur J Cancer; 2014 Oct; 50(15):2570-82. PubMed ID: 25091797
[TBL] [Abstract][Full Text] [Related]
37. CD10-positive stromal cells in gastric carcinoma: correlation with invasion and metastasis.
Huang WB; Zhou XJ; Chen JY; Zhang LH; Meng K; Ma HH; Lu ZF
Jpn J Clin Oncol; 2005 May; 35(5):245-50. PubMed ID: 15886270
[TBL] [Abstract][Full Text] [Related]
38. The expression of matrix metalloproteinases-2 and -9 and their tissue inhibitor 2 in pancreatic ductal and ampullary carcinoma and their relation to angiogenesis and clinicopathological parameters.
Giannopoulos G; Pavlakis K; Parasi A; Kavatzas N; Tiniakos D; Karakosta A; Tzanakis N; Peros G
Anticancer Res; 2008; 28(3B):1875-81. PubMed ID: 18630474
[TBL] [Abstract][Full Text] [Related]
39. Podoplanin expression in cancer-associated fibroblasts enhances tumor progression of invasive ductal carcinoma of the pancreas.
Shindo K; Aishima S; Ohuchida K; Fujiwara K; Fujino M; Mizuuchi Y; Hattori M; Mizumoto K; Tanaka M; Oda Y
Mol Cancer; 2013 Dec; 12(1):168. PubMed ID: 24354864
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic cancer: the role of pancreatic stellate cells in tumor progression.
Dunér S; Lopatko Lindman J; Ansari D; Gundewar C; Andersson R
Pancreatology; 2010; 10(6):673-81. PubMed ID: 21242706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
